Coronavirus (COVID-19) Collection
Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
Healthcare workers (HCWs) are at risk for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection due to increased occupational exposure to SARS-CoV-2 (Nguyen et al., 2020). As well as being beneficial for the HCWs themselves, protecting HCWs from SARS-CoV-2 infection is important to prevent disease transmission in healthcare and community settings (Anonymous, 2020). In addition, protecting HCWs from coronavirus disease 2019 (COVID-19) is crucial for the preservation and protection of national healthcare systems (Anonymous, 2020).Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
The SARS-CoV-2 pandemic has resulted in an unprecedented need for reliable commercial laboratory diagnostics. While SARS-CoV-2 antibody assays have recently become commercially available, performance data have mainly assessed high-income country populations (Van Walle et al., 2020), with data from populations of mostly African descent lacking. To our knowledge, there has been no published performance assessment of SARS-CoV-2 antibody assays with a predominantly black population. In this study in Jamaica, serum samples were used to assess the diagnostic sensitivity and specificity of the Roche Elecsys® Anti-SARS-CoV-2, Abbott Architect SARS-CoV-2 IgM and IgG, Euroimmun SARS-CoV-2 IgA and IgG, and Trillium IgG/IgM assays.
